ReviewCurrent opinion in obstetrics & gynecology2017
Use of fertility medications and cancer risk: a review and update.
Review in Current opinion in obstetrics & gynecology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 53 citations in OpenAlex.
- Repeated gonadotropin stimulation modulates the expression of specific proteins in mouse oviduct.JBRA assisted reproduction · 2025Article
- Bridging Andrology and Oncology: Prognostic Indicators of Cancer Among Infertile Men.Current issues in molecular biology · 2025Review
- Fertility treatment and risk of non-Hodgkin lymphoma - results from a Danish population-based cohort study.Cancer causes & control : CCC · 2025Article
- Synchronous Endometrial and Ovarian Adenocarcinomas in a 43-Year-Old Patient Following Infertility Treatment: A Case Report.Diagnostics (Basel, Switzerland) · 2025Article
- Infertility and risk of ovarian cancer: A systematic review and meta analysis.Journal of family medicine and primary care · 2025Review
- Environment and gynaecologic cancers.Oncology reviews · 2024Review
- Article
- In vitro fertilization impact on the risk of breast cancer.Archive of clinical cases · 2024Review
- Androgen receptor expression in low grade serous ovarian cancer; clinical considerations in the diagnosis, treatment and surveillance of disease in a transgender male.Gynecologic oncology reports · 2023Article
- Polycystic ovary syndrome and thyroid disorder: a comprehensive narrative review of the literature.Frontiers in endocrinology · 2023Review
- Hormone therapy and melanoma in women.International journal of women's dermatology · 2021Review
- In-Vitro Fertilization Impact on the Risk of Breast Cancer: A Review Article.Iranian journal of public health · 2021Review
- The significance of ovarian fibrosis.Oncotarget · 2020Article
- Exploring Reproductive Health Education Needs in Infertile Women in Iran: A Qualitative Study.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2020Article
- Repeated hyperstimulation affects the ultrastructure of mouse fallopian tube epithelium.The Journal of reproduction and development · 2020Article
- Strong Evidences of the Ovarian Carcinoma Risk in Women after IVF Treatment: A Review Article.Iranian journal of public health · 2019Review
- Ddx4Cells · 2019Review
- Article
- The risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based study.European journal of epidemiology · 2019Article
- Long-term effect of pregnancy-related factors on the development of endometrial neoplasia: A nationwide retrospective cohort study.PloS one · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
purpose of reviewThere is increasing use of fertility medications for ovulation induction and ovarian stimulation for in-vitro fertilization in the treatment of female infertility. In this review, recent literature regarding the association between fertility medication and cancer risk is reviewed. RECENT
findingsSeveral important publications have recently addressed the relationship between use of fertility medications and cancer risk. There are methodological limitations to many of these studies, including unique challenges in studying rare cancers that often develop several years after the time of fertility medication exposure. Although infertility per se is a risk factor for some female cancers, including breast, endometrial and ovarian cancer, most studies do not show a significant risk of these cancers with the use of fertility medications. Some studies, however, have shown a possible increased relative risk of borderline ovarian cancer, although the increased absolute risk is small without a clear causal relationship. SUMMARY: The collective data regarding the risk of developing cancer from use of fertility medications are reassuring, although several methodological issues in these studies limit definitive conclusions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.